Faes Farma, S.A. (LON:0K9H)

London flag London · Delayed Price · Currency is GBP · Price in EUR
4.570
-0.085 (-1.84%)
At close: Mar 13, 2026
Market Cap1.23B +37.1%
Revenue (ttm)546.97M +22.9%
Net Income69.47M -28.5%
EPS0.22 -28.7%
Shares Outn/a
PE Ratio17.64
Forward PE15.20
Dividend0.13 (2.74%)
Ex-Dividend DateJan 8, 2026
Volume3,110
Average Volume9,678
Open4.600
Previous Close4.655
Day's Range4.550 - 4.655
52-Week Range3.270 - 5.480
Beta0.24
RSI24.57
Earnings DateFeb 26, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. The company also engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, sec... [Read more]

Industry Pharmaceutical Preparations
Founded 1933
Employees 1,894
Stock Exchange London Stock Exchange
Ticker Symbol 0K9H
Full Company Profile

Financial Performance

In 2025, Faes Farma's revenue was 626.99 million, an increase of 22.93% compared to the previous year's 510.04 million. Earnings were 79.63 million, a decrease of -28.49%.

Financial numbers in EUR Financial Statements